Patient - centric healthcare solutions

Search documents
Catheter Precision Receives Approval for LockeT in the United Kingdom
Globenewswire· 2025-08-18 12:00
Core Insights - Catheter Precision, Inc. has received registration and approval for its LockeT product in the United Kingdom, which is a significant step for the company to launch sales in the UK market [1] - The LockeT product, a suture retention device, previously received CE Mark approval for European distribution in May 2025 [1][4] - The partnership with HC21, a UK-based distributor, aims to enhance market access for LockeT, leveraging HC21's annual revenue of €180 million and extensive network in the medical device sector [2] Product Details - LockeT is designed to assist in wound closure after percutaneous venous punctures and is classified as a Class 1 device registered with the FDA [4] - The product's intuitive design is expected to improve patient comfort and recovery, facilitating earlier discharge after cardiac procedures [3] Market Impact - The introduction of LockeT is aligned with the NHS's efforts to reduce waiting lists, which recently saw its first reduction in 17 years, potentially allowing clinicians to deliver more treatments efficiently [3] - Catheter Precision aims to collaborate closely with UK healthcare providers to maximize the benefits of LockeT for patients across the nation [3]